Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the
treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care …

Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …

Accelerated and premature cardiovascular calcification is a hallmark of patients with chronic
kidney disease (CKD) or end-stage renal disease (ESRD). The presence and the amount of …

Objectives The aim of this study was to compare 5-year cardiovascular, renal, and
bioprosthetic valve durability outcomes in patients with severe aortic stenosis (AS) and …

Background: Patients with end-stage renal disease on hemodialysis (ESRD-HD) and aortic
stenosis have poor prognosis. The role of transcatheter aortic valve replacement (TAVR) in …

Valvular heart calcification is common in patients with chronic kidney disease (CKD),
especially in those receiving hemodialysis therapy, and it is associated with poor prognosis …

Background Patients with advanced chronic kidney disease (CKD) are a challenging and
understudied population. Specifically, the late outcomes following surgical aortic valve …

Aortic stenosis is the most common cause of valve replacement in Europe and North
America with prevalence increasing with age. Transcatheter valve replacement (TAVR) …

Objective We compared TAVI vs. SAVR in patients with moderate-to-severe chronic kidney
disease (eGFR 15–60 ml/min/1.73 m2) for whom both procedures could possibly be …

OBJECTIVES Chronic kidney disease (CKD) is a key risk factor in patients undergoing
transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) …